INTERNATIONAL ROW

Having corporate office in Mumbai-India, Moscow-Russia, Kiev-Ukraine, & Minsk-Belarus, Lok-Beta is able to expend its marketing operations in Asia Pacific, Latin America and Africa Market covering more than 23 countries.

• Asia Pacific: Bhutan, Sri-Lanka, Myanmar, Philippines, Thailand, Vietnam, Yemen, Malaysia, Indonesia, Singapore
• Latin America: Bolivia, Guatemala, Paraguay, Trinidad, Brazil, Colombia, Argentina, Nicaragua, Chili, Costa Rica
• Africa: Ethiopia, Namibia, Nigeria

Fight against Novel Coronavirus ( COVID-19)

LOPIRAVIR - 250 mg / 125 mg (Lopinavir 200 mg & Ritonavir 50mg) Manufactured by J Duncan Healthcare Pvt. Ltd, Marketed by LOK-BETA Pharmaceuticals (I) Pvt. Ltd.

TINAROVIR - 125 mg (Lopinavir 200 mg & Ritonavir 50mg) Marketed and Manufactured by LOK-BETA Pharmaceuticals (I) Pvt. Ltd.

Producs :

The majority of products marketed are for the treatment and/or prevention of chronic and recurrent illness.

• ARV’S (Anti – HIV)
• Anti-Diabetic
• Antibiotics
• Immunosuppressants
• Anti-Hypertensive
• Gastroenterology
• Anti -TB
• Anti – Inflammatory

For details please visit Product menu

Business Module

• Offer opportunities to our associates to run a small to medium sized profitable entrepreneurship by offering them technical know-how with the empowerment and accountability within the core values and system of the company.
• Aiming to enable service towards broader segment of the pharmaceuticals & healthcare markets.
• Products which matches its rigorous marketing, stringent quality norms and financial return criteria.

Methodology :

The company has extensive database and obtains regular feedback on customer purchasing patterns and preferences and doctor prescribing habits. These detailed information's are used to direct the company's promotional spend, sales force activity, product development programmes and to identify new product opportunities.